Fundamentals Hub
HOTH Hoth Therapeutics, Inc.
HOTH financial statements, revenue, balance sheet, cash flow, and SEC filings
Showing 3 of 8 annual and 0 of 34 quarterly periods.
Full history available with a free account or via API.
▼ Company Profile
Filer Category
Non-accelerated filer<br>Smaller reporting company
Entity Type
Operating
Public Float
$15.40M (Jun 2025)
Industry (SIC)
2834 Pharmaceutical Preparations
Incorporated
NV
Fiscal Year End
December (1231)
Phone
(866) 239-7459
EIN
821553794
Headquarters
HOBOKEN, NJ, 07030
Public Float History
Market value of shares held by public investors, reported in annual DEI filings.
Former Names:
Hoth Therapeutics, Inc. (2017–2026)
▼ Key Metrics (TTM)
As of Jun 30, 2026Financials
Revenue
-
Net Income
$-13.32M
Total Assets
$9.58M
Total Equity
$8.20M
Total Debt
-
Free Cash Flow
-
Ratios
Return on Equity
-162.4%
Return on Assets
-139%
Current Ratio
6.2x
Sources and calculation details
Reported values are preserved. Derived values use the listed inputs; unavailable inputs remain blank.
Field-level sources for this historical record are unavailable until it is rebuilt from SEC facts.
Annual (FY)
Quarterly 🔒
Chart 🔒
| Metric | FY2025 📄 | FY2024 📄 | FY2023 📄 |
|---|---|---|---|
| Income Statement | |||
| REVENUE | |||
| OPERATING EXPENSES | |||
| R&D Expense | $5.95M | $3.25M | $3.74M |
| SG&A Expense | $6.41M | $4.97M | $4.21M |
| Operating Income | $-12.36M | $-8.22M | $-7.95M |
| NON-OPERATING INCOME / EXPENSE | |||
| Interest Income | - | - | $781 |
| Other Income/Expense | $-107.95K | $27.13K | $-153.15K |
| Net Income | $-12.47M | $-8.19M | $-8.11M |
| PER SHARE & SUPPLEMENTAL | |||
| Diluted EPS | $-0.90 | $-1.28 | $-2.38 |
| Diluted Shares | 13.81M | 6.38M | 3.41M |
| Balance Sheet | |||
| ASSETS | |||
| Cash & Equivalents | $6.25M | $7.04M | $9.29M |
| Other Current Assets | $366.55K | $605.95K | $858.13K |
| Current Assets | $6.86M | $7.64M | $10.15M |
| Noncurrent Assets | $740.89K | $67.89K | $92.57K |
| Total Assets | $7.60M | $7.71M | $10.24M |
| LIABILITIES | |||
| Accounts Payable | $823.67K | $412.07K | $35.59K |
| Current Liabilities | $1.45M | $831.20K | $678.66K |
| Noncurrent Liabilities | $0 | $2.71K | $26.33K |
| Total Liabilities | $1.45M | $833.91K | $704.98K |
| EQUITY | |||
| Common Stock | $1.55K | $804 | $435 |
| Additional Paid-in Capital | $79.02M | $67.28M | $61.73M |
| Retained Earnings | $-72.88M | $-60.41M | $-52.22M |
| Accumulated OCI | $10.83K | $9.06K | $27.26K |
| Total Equity | $6.15M | $6.88M | $9.54M |
| Total Liabilities & Equity | $7.60M | $7.71M | $10.24M |
| SUPPLEMENTAL | |||
| Shares Outstanding | 15.51M | 8.04M | 4.35M |
| Check: A − (L + E + NCI) | - | - | - |
| Cash Flow Statement | |||
| Cash from Operations | $-9.80M | $-6.98M | $-8.45M |
| Capital Expenditures | - | - | - |
| Cash from Investing | $-300.00K | - | - |
| Cash from Financing | $9.31M | $4.74M | $11.32M |
| Free Cash Flow | - | - | - |
| Beginning Cash (CFS) | $7.04M | $9.29M | - |
| Net Change in Cash | $-793.22K | - | - |
| Effect of FX on Cash | $1.77K | $-18.20K | $-6.52K |
| Calculated Ending Cash | $6.25M | - | - |
| Cash per BS | $6.25M | $7.04M | $9.29M |
| Cash scope difference (CFS − BS) | - | - | - |
| Cash per CFS | $6.25M | $7.04M | $9.29M |
Create a free account to see full history, quarterly data, charts, CSV downloads, and API access.
Create Free Account Log In🔒
Quarterly data and charts require a free account
Get access to 8 quarters of data, interactive charts, CSV downloads, and API access.
▼ Frequently Asked Questions
Is Hoth Therapeutics, Inc. profitable?
No. Hoth Therapeutics, Inc. reported $-13.32M in net income for trailing twelve months. Profitability data is based on the company's most recent annual report filed with the SEC.